Cargando…

AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody

Detalles Bibliográficos
Autores principales:	Ilieva, Kristina M., Fazekas‐Singer, Judit, Bax, Heather J., Crescioli, Silvia, Montero‐Morales, Laura, Mele, Silvia, Sow, Heng Sheng, Stavraka, Chara, Josephs, Debra H., Spicer, James F., Steinkellner, Herta, Jensen‐Jarolim, Erika, Tutt, Andrew N. J., Karagiannis, Sophia N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817356/ https://www.ncbi.nlm.nih.gov/pubmed/30964550 http://dx.doi.org/10.1111/all.13818

Ejemplares similares

Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology
por: Crescioli, Silvia, et al.
Publicado: (2018)

AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice
por: Singer, Josef, et al.
Publicado: (2019)

AllergoOncology – the impact of allergy in oncology: EAACI position paper
por: Jensen‐Jarolim, E., et al.
Publicado: (2017)

AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper
por: Untersmayr, Eva, et al.
Publicado: (2019)

AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)
por: Ferastraoaru, D., et al.
Publicado: (2020)

AllergoOncology: Role of immune cells and immune proteins
por: Di Gioacchino, Mario, et al.
Publicado: (2022)

AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
por: Bergmann, Christoph, et al.
Publicado: (2022)

In Planta Glycan Engineering and Functional Activities of IgE Antibodies
por: Montero-Morales, Laura, et al.
Publicado: (2019)

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021)

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model
por: Williams, Iwan P., et al.
Publicado: (2019)

IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
por: Ilieva, Kristina M., et al.
Publicado: (2017)

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
por: Pellizzari, Giulia, et al.
Publicado: (2019)

Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG(1) and IgG(4) against the Major Birch Pollen Allergen Bet v 1
por: Köhler, Verena K., et al.
Publicado: (2020)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
por: Bax, Heather J., et al.
Publicado: (2020)

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
por: Nakamura, Mano, et al.
Publicado: (2020)

Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
por: Chauhan, Jitesh, et al.
Publicado: (2023)

PIPE‐cloned human IgE and IgG4 antibodies: New tools for investigating cow's milk allergy and tolerance
por: Pranger, Christina L., et al.
Publicado: (2020)

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
por: Ilieva, Kristina M., et al.
Publicado: (2018)

Guideline for authors: Allergo Journal International
por: Weber, Marion
Publicado: (2015)

Author guidelines: Allergo Journal International
por: Weber, Marion
Publicado: (2014)

Author guidelines: Allergo Journal International
por: Weber, Marion
Publicado: (2014)

An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE
por: Josephs, D. H., et al.
Publicado: (2018)

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
por: Pellizzari, Giulia, et al.
Publicado: (2021)

BRAF inhibitors: resistance and the promise of combination treatments for melanoma
por: Griffin, Merope, et al.
Publicado: (2017)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
por: Correa, Isabel, et al.
Publicado: (2018)

Allergo Journal und DGAKI gehen getrennte Wege
por: Jakob, Thilo, et al.
Publicado: (2020)

Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016)

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
por: Chiaruttini, Giulia, et al.
Publicado: (2017)

Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
por: Osborn, Gabriel, et al.
Publicado: (2021)

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
por: Spicer, James, et al.
Publicado: (2023)

The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer
por: Bianchini, Rodolfo, et al.
Publicado: (2020)

Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome
por: Bax, Heather J., et al.
Publicado: (2020)

IgE-based immunotherapy of cancer: challenges and chances
por: Singer, J, et al.
Publicado: (2014)

IgE Antibodies: From Structure to Function and Clinical Translation
por: Sutton, Brian J., et al.
Publicado: (2019)

Erfreuliches in COVID-19-Zeiten: Allergo Journal im JCR gelistet!
por: Jakob, Thilo, et al.
Publicado: (2021)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7cq7k4uipsl9qm1jga5k94ct0d